20 March 2021>: Database Analysis
Potential Target Genes in the Development of Atrial Fibrillation: A Comprehensive Bioinformatics Analysis
Liang Liu CE* , Yun Yu BC* , Long-long Hu D , Quan-bin Dong D , Feng Hu D , Ling-juan Zhu D , Qian Liang D , Ling-ling Yu B , Hui-hui Bao A*** , Xiao-shu Cheng A***DOI: 10.12659/MSM.928366
Med Sci Monit 2021; 27:e928366
Table 2 Significantly enriched pathways in AF.
Rank | Pathway | Genes |
---|---|---|
1 | infection | C1QA; C1QB; FPR2; HLA-DPB1; FCGR3B; C1QC; HLA-DQA1; HLA-DRA |
2 | Intestinal immune network for IgA production | CXCR4; TNFRSF17; ITGA4; HLA-DPB1; HLA-DQA1; HLA-DRA; CD28 |
3 | Chemokine signaling pathway | HRAS; PPBP; RAC2; GNB2; ARRB2; CXCR4; PREX1; HCK; CCR2; CCL19; CXCR2 |
4 | Systemic lupus erythematosus | C1QA; C1QB; HLA-DPB1; FCGR3B; HIST1H3G; C1QC; HLA-DQA1; HLA-DRA; CD28 |
5 | Asthma | FCER1G; MS4A2; HLA-DPB1; HLA-DQA1; HLA-DRA |
6 | Osteoclast differentiation | CYBA; JUND; LILRA6; SPI1; FHL2; FCGR3B; BLNK; TYROBP |
7 | Leishmaniasis | CYBA; ITGA4; HLA-DPB1; FCGR3B; HLA-DQA1; HLA-DRA |
8 | Cytokine-cytokine receptor interaction | IL1R2; PPBP; CXCR4; CCR2; CCL19; TNFRSF17; CSF3R; CXCR2; CSF2RA; CD27 |
9 | Natural killer cell mediated cytotoxicity | HRAS; RAC2; FCER1G; FCGR3B; KLRD1; TYROBP; HCST |
10 | Hematopoietic cell lineage | IL1R2; CSF3R; ITGA4; CD1E; CSF2RA; HLA-DRA |
11 | Viral myocarditis | RAC2; HLA-DPB1; HLA-DQA1; HLA-DRA; CD28 |
12 | Graft-versus-host disease | HLA-DPB1; HLA-DQA1; HLA-DRA; CD28 |
13 | Cell adhesion molecules (CAMs) | SELL; ITGA4; HLA-DPB1; JAM3; HLA-DQA1; HLA-DRA; CD28 |
14 | Allograft rejection | HLA-DPB1; HLA-DQA1; HLA-DRA; CD28 |
15 | Phagosome | CYBA; CORO1A; COMP; HLA-DPB1; FCGR3B; HLA-DQA1; HLA-DRA |
16 | Type I diabetes mellitus | HLA-DPB1; HLA-DQA1; HLA-DRA; CD28 |
17 | Leukocyte transendothelial migration | CYBA; RAC2; CXCR4; ITGA4; JAM3; CTNNB1 |
18 | Autoimmune thyroid disease | HLA-DPB1; HLA-DQA1; HLA-DRA; CD28 |